Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Natera OncologyNatera Oncology
VS
BioconBiocon
Natera Oncology

Natera Oncology

13011A McCallen Pass , Austin, TX, 78753, US

Last Update: 03/11/2025

View Profile

Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer. Follow us on Twitter: @NateraOncology

NAICS:541
NAICS Definition:N/A
Employees:0
Subsidiaries:3
12-month incidents
0
Known data breaches
0
Attack type number
0
Biocon

Biocon

Hosur Road, Electronics City, Bangalore, Karnataka, IN, 560100

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.biocon.com
773/1000Fair

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:11,558
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Natera Oncology

Natera Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Biocon

Biocon

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Natera Oncology in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biocon in 2026.

Incidents

Incident History - Natera Oncology (X = Date, Y = Severity)

Natera Oncology cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Biocon (X = Date, Y = Severity)

Biocon cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Natera Oncology

Natera Oncology

Incidents
No explicit notable incidents reported.
Biocon

Biocon

Incidents
No explicit notable incidents reported.

FAQ

Between Natera Oncology company and Biocon company, which one has the best AI Cybersecurity Score ?
Between Natera Oncology company and Biocon company, which one has experienced more cyber incidents in the past ?
Between Natera Oncology company and Biocon company, which one has experienced more cyber incidents this year ?
Between Natera Oncology company and Biocon company, which one has experienced at least one ransomware attack ?
Between Natera Oncology company and Biocon company, which one has experienced at least one data breach ?
Between Natera Oncology company and Biocon company, which one has experienced at least one targeted cyberattack ?
Between Natera Oncology company and Biocon company, which one has experienced at least one vulnerability ?
Between Natera Oncology company and Biocon company, which one holds the most compliance certifications ?
Between Natera Oncology company and Biocon company, which one holds the fewest compliance certifications ?
Between Natera Oncology company and Biocon company, which one has the most subsidiaries ?
Between Natera Oncology company and Biocon company, which one has the largest number of employees ?
Between Natera Oncology and Biocon, which company holds both SOC 2 Type 1 certifications ?
Between Natera Oncology and Biocon, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Natera Oncology or Biocon ?
Which company is PCI DSS compliant - Natera Oncology or Biocon ?
Between Natera Oncology and Biocon, which company complies with HIPAA regulations for healthcare data ?
Between Natera Oncology and Biocon, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-100739
SUMMARY

A vulnerability was detected in mathurvishal CloudClassroom-PHP-Project up to 5dadec098bfbbf3300d60c3494db3fb95b66e7be. This impacts an unknown function of the file viewresult.php. Performing a manipulation of the argument seno results in sql injection. Remote exploitation of the attack is possible. The exploit is now public and may be used. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9
CVE-2026-94408
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
CVE-2026-94400
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-94399
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-94398
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)

PUBLISHED
Date2026-09-26
UPDATED
Date2026-09-26
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8